Cancer trials: Search results
Results: 12 items found.
Refine results
Capturing Canadian Real-World Data for AML Chemotherapy Ineligible Patients on Venetoclax
Trial short name: Abbvie LIVEN
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase: Other
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Acalabrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects ≤65 Years with Previously Untreated Non-Germinal Center Diffuse Large B-Cell Lymphoma (ACE LY 312 Escalade)
Trial short name: ACE LY 312
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase: Phase 3
Phase 1-2 Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX660 in Subjects with Advanced Solid Tumors and Lymphomas
Trial short name: Astex 660
Cancer type: Blood Related
Cancer location: Lymphoma
Disease stage: Early and Advanced Cancer
Trial phase: Phase 2
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions (ELEMENT-MDS)
Trial short name: BMS 025 ELEMENT
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase: Phase 3
Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia (BRAWM)
Trial short name: Brawm
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase:
Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications
Trial short name: CHIP
Cancer type: Blood Related
Cancer location: Lymphoma
Disease stage: Early Cancer
Trial phase: Other
A Phase 1/2, Open-Label, Dose-Escalation Trial of GEN3013 in Patients with Relapsed, Progressive or Refractory B-Cell Lymphoma (Genmab 01)
Trial short name: Genmab 01
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase: Phase 1, Phase 2
A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) that is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment
Trial short name: Geron MDS Imerge
Cancer type: Blood Related
Cancer location: Myelodysplastic Syndromes
Disease stage: Early Cancer
Trial phase: Phase 2, Phase 3
Sunnybrook Hematology Biobank (CMH Biobank)
Trial short name: Heme Biobank
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase:
Management of National MDS Clinical Database and Local Tissue Bank
Trial short name: MDS Database
Cancer type: Blood Related
Cancer location: Myelodysplastic Syndromes
Disease stage: Other
Trial phase: Other
Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
Trial short name: PNH Registry
Cancer type: Blood Related
Cancer location: Paroxysmal Nocturnal Hemoglobinuria
Disease stage: Other
Trial phase: Other
A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera (PTG 300 11)
Trial short name: PTG 300 11
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase: Phase 3
